Abstract |
The histiocytoses are a group of rare disorders characterised by the accumulation of neoplastic or non-neoplastic activated histiocytes in various tissues. Phenotypes vary widely from cutaneous lesions or lymphadenopathy that regress spontaneously to disseminated disease with poor prognosis. Neurological symptoms can be a presenting feature or appear during the course of disease. We present a challenging diagnostic and management case of Rosai-Dorfman-Destombes disease in a 48-year-old woman with a relapsing, partially steroid-responsive syndrome comprising patchy, non-length-dependent radiculoneuropathy with diffuse pachymeningitis and widespread systemic disease, and recent dramatic response to novel mitogen-activated kinase pathway inhibition. We discuss the clinical characteristics, diagnosis, recent breakthroughs in pathogenesis and emerging treatment options for Rosai-Dorfman disease and for the histiocytoses with neurological sequelae, including Langerhans cell histiocytosis and Erdheim-Chester disease.
|
Authors | Antonia S Carroll, Carolynne M Doherty, Julian Blake, Stephen J Hunt, Chandrashekar Hoskote, Feargal McNicholl, Rahul Phadke, Oonagh Sheehy, Fion D Bremner, Shirley D'Sa, Christopher McNamara, Mary M Reilly |
Journal | Practical neurology
(Pract Neurol)
(May 09 2022)
ISSN: 1474-7766 [Electronic] England |
PMID | 35534197
(Publication Type: Journal Article)
|
Copyright | © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. |